- Home
- JOB vs IGC Comparison
JOB vs IGC Comparison
Compare JOB & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- IGC
- Stock Information
- Founded
- JOB 1893
- IGC 2005
- Country
- JOB United States
- IGC United States
- Employees
- JOB N/A
- IGC N/A
- Industry
- JOB Diversified Commercial Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- IGC Health Care
- Exchange
- JOB Nasdaq
- IGC Nasdaq
- Market Cap
- JOB 28.3M
- IGC 26.9M
- IPO Year
- JOB N/A
- IGC N/A
- Fundamental
- Price
- JOB $0.24
- IGC $0.34
- Analyst Decision
- JOB
- IGC Strong Buy
- Analyst Count
- JOB 0
- IGC 2
- Target Price
- JOB N/A
- IGC $3.63
- AVG Volume (30 Days)
- JOB 156.2K
- IGC 246.6K
- Earning Date
- JOB 12-16-2024
- IGC 11-12-2024
- Dividend Yield
- JOB N/A
- IGC N/A
- EPS Growth
- JOB N/A
- IGC N/A
- EPS
- JOB N/A
- IGC N/A
- Revenue
- JOB $122,402,000.00
- IGC $1,183,000.00
- Revenue This Year
- JOB N/A
- IGC N/A
- Revenue Next Year
- JOB $18.60
- IGC $13.57
- P/E Ratio
- JOB N/A
- IGC N/A
- Revenue Growth
- JOB N/A
- IGC N/A
- 52 Week Low
- JOB $0.23
- IGC $0.25
- 52 Week High
- JOB $0.56
- IGC $0.91
- Technical
- Relative Strength Index (RSI)
- JOB 37.27
- IGC 29.55
- Support Level
- JOB $0.24
- IGC $0.38
- Resistance Level
- JOB $0.27
- IGC $0.42
- Average True Range (ATR)
- JOB 0.01
- IGC 0.02
- MACD
- JOB -0.00
- IGC -0.01
- Stochastic Oscillator
- JOB 5.03
- IGC 2.83
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.